Antitrust Law Daily Wrap Up, CONFERENCES: Global Antitrust Institute to host pharmaceutical industry antitrust conference, (Jul 24, 2014)

By Greg Hammond, J.D.

George Mason University School of Law’s Global Antitrust Institute is hosting a conference, entitled “Global Antitrust Challenges for the Pharmaceutical Industry,” on September 23, 2014. The conference, which will take place at the J.W. Marriott Hotel in D.C. from 8:30 a.m. to 6:30 p.m., will feature a number of panels, including notable antitrust officials from the U.S. and abroad.

The conference will open with introductory remarks by George Mason University School of Law professor Damien Feradin and a keynote address presented by FTC Chairwoman Edith Ramirez. The remainder of the conference will include the following panels and speakers:

Panel 1: Competition Policy and Life-Cycle Management Strategies—Michael A. Carrier; Ingrid Vandenborre; Chief of the New York Attorney General’s office Antitrust Bureau, Eric J. Stock; Aaron Gal; Heather M. Johnson; and James M. Spears.
Panel 2: Antitrust and Reverse Settlements: Unsettled Issues—Assistant Director of the FTC’s Health Care Division, Markus H. Meier; EC Deputy Head of Unit Henri Piffaut; Korea Fair Trade Commission Deputy Director Yoonhwan Hwang; Marc E. Levin; Sumanth Addanki; and Henry N. Butler.
Luncheon—Canadian Commissioner of Competition, John Pecman
Panel 3: Antitrust in Pharmaceutical Markets: When the Government is the Consumer—Herbert Hovenkamp; Italian Competition Authority Chairman Giovani Pitruzzela; Senior Director of the U.K. Competition and Markets Authority, Claudia Berg; Dutch Competition Authority legal counsel Kees Hellingman; John D. Graubert; and Jonathan B. Baker.
Panel 4: Rebates and Tying: Implications for Pharmaceutical Competition—FTC Commissioner Joshua D. Wright; Damien Geradin; Abbott B. Lipsky, Jr.; Hal J. Singer; D. Daniel Sokol; and the Honorable Douglas H. Ginsburg.
Panel 5: Merger Control in the Pharmaceutical Industry—Assistant Director of the FTC Bureau of Competition, Michael R. Moiseyev; EC Director Paul Csiczár; Ilene K. Gotts; Monica Noether; George S. Cary; and Timothy J. Muris.

For additional information, contact Jeff Smith at the Global Antitrust Institute. Call 703-993-8382; email jsmithq@gmu.edu; or visit the event website.

News: Conferences Antitrust

Antitrust Law Daily Wrap Up, CONFERENCES: Global Antitrust Institute to host pharmaceutical industry antitrust conference, (Jul 24, 2014)

By Greg Hammond, J.D.

Panel 1: Competition Policy and Life-Cycle Management Strategies—Michael A. Carrier; Ingrid Vandenborre; Chief of the New York Attorney General’s office Antitrust Bureau, Eric J. Stock; Aaron Gal; Heather M. Johnson; and James M. Spears.
Panel 2: Antitrust and Reverse Settlements: Unsettled Issues—Assistant Director of the FTC’s Health Care Division, Markus H. Meier; EC Deputy Head of Unit Henri Piffaut; Korea Fair Trade Commission Deputy Director Yoonhwan Hwang; Marc E. Levin; Sumanth Addanki; and Henry N. Butler.
Luncheon—Canadian Commissioner of Competition, John Pecman
Panel 3: Antitrust in Pharmaceutical Markets: When the Government is the Consumer—Herbert Hovenkamp; Italian Competition Authority Chairman Giovani Pitruzzela; Senior Director of the U.K. Competition and Markets Authority, Claudia Berg; Dutch Competition Authority legal counsel Kees Hellingman; John D. Graubert; and Jonathan B. Baker.
Panel 4: Rebates and Tying: Implications for Pharmaceutical Competition—FTC Commissioner Joshua D. Wright; Damien Geradin; Abbott B. Lipsky, Jr.; Hal J. Singer; D. Daniel Sokol; and the Honorable Douglas H. Ginsburg.
Panel 5: Merger Control in the Pharmaceutical Industry—Assistant Director of the FTC Bureau of Competition, Michael R. Moiseyev; EC Director Paul Csiczár; Ilene K. Gotts; Monica Noether; George S. Cary; and Timothy J. Muris.

For additional information, contact Jeff Smith at the Global Antitrust Institute. Call 703-993-8382; email jsmithq@gmu.edu; or visit the event website.

News: Conferences Antitrust